FIELD: medicine, ophthalmology.
SUBSTANCE: one should daily introduce medicinal mixture consisting of lidocaine, retiling, dalargin, mildronate and lidase into orbital lymphatic area, about 8-10 procedures/course followed by discrete plasmapheresis by activating cell mass due to incubation with mexidole and irradiating with ultraviolet in the course of re-infusion. The innovation provides improved visual functions due to correcting biochemical and microcirculatory disorders.
EFFECT: higher efficiency of therapy.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING OEDEMATOUS FORM OF DIABETIC MACULORETINOPAHTY | 2008 |
|
RU2367386C1 |
| METHOD OF TREATING OPTIC NERVE ATROPHY OF VASCULAR GENESIS | 2011 |
|
RU2452436C1 |
| METHOD FOR TREATING PATIENTS FOR RECURRENT UVEITIS | 2005 |
|
RU2299065C1 |
| METHOD FOR TREATING PATIENTS FOR PRE- AND PROLIFERATIVE RETINOPATHY | 2005 |
|
RU2283647C1 |
| METHOD FOR COMPLEX TREATMENT OF ENDOGENOUS UVEITIS FOLLOWED BY MACULAR EDEMA | 2016 |
|
RU2635083C1 |
| METHOD FOR TREATING DIABETIC RETINOPATHY | 1999 |
|
RU2157154C1 |
| METHOD FOR THE TREATMENT OF OPTIC NEUROPATHY IN PATIENTS WITH EDEMATOUS EXOPHTHALMOS | 2020 |
|
RU2742188C1 |
| METHOD FOR TREATMENT OF GLAUCOMA OPTICAL NEUROPATHY | 2005 |
|
RU2284192C1 |
| METHOD OF TREATING INFLAMMATORY OR DYSTROPHIC EYE DISEASES | 2019 |
|
RU2714193C1 |
| METHOD FOR TREATING PRE- AND PROLIFERATIVE DIABETIC RHETINOPATHY | 1996 |
|
RU2123829C1 |
